Home › Funds › Evergreen Quality Fund GP, Ltd. › ERAS
Evergreen Quality Fund GP, Ltd. position in ERAS
ERASCA INC · Health Care
Evergreen Quality Fund GP, Ltd. reported holding 1,375,300 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$20.2M, representing 0.28% of its reported portfolio and ranking #41 among its reported holdings. Evergreen Quality Fund GP, Ltd. has disclosed ERAS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Evergreen Quality Fund GP, Ltd.'s ERAS position evolved
Evergreen Quality Fund GP, Ltd. first disclosed a stake in ERAS in Q2 2026 at 1,375,300 shares (US$25.2M). Across 2 filings, Evergreen Quality Fund GP, Ltd. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,375,300 shares valued at US$20.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.38M | $25.20M | New |
| Q3 2026 | 1.38M | $20.16M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (ERASCA INC) is a Health Care company. 63 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$432.1M), RTW INVESTMENTS, LP (US$329.1M), Venrock Adviser, LLC (US$294.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- Frazier Life Sciences Management, L.P. 29.48M sh · $432.11M · Q3 2026
- RTW INVESTMENTS, LP 22.45M sh · $329.07M · Q3 2026
- Venrock Adviser, LLC 20.09M sh · $294.52M · Q3 2026
- Siren, L.L.C. 13.20M sh · $193.48M · Q3 2026
- Paradigm Biocapital Advisors LP 8.00M sh · $117.25M · Q3 2026
- ARCH Venture Management, LLC 7.09M sh · $103.96M · Q3 2026
- Affinity Asset Advisors, LLC 5.59M sh · $81.96M · Q3 2026
- Soleus Capital Management, L.P. 5.11M sh · $74.94M · Q3 2026
- Cormorant Asset Management, LP 5.00M sh · $73.30M · Q3 2026
- Vivo Capital, LLC 4.02M sh · $58.94M · Q3 2026
- EcoR1 Capital, LLC 2.95M sh · $43.25M · Q3 2026
- SAMLYN CAPITAL, LLC 2.54M sh · $37.29M · Q3 2026
More on Evergreen Quality Fund GP, Ltd.
FAQ
How long has Evergreen Quality Fund GP, Ltd. held ERAS?
Evergreen Quality Fund GP, Ltd. has disclosed ERAS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Evergreen Quality Fund GP, Ltd.'s current position in ERAS?
As of Q3 2026, Evergreen Quality Fund GP, Ltd. holds 1.38M shares of ERAS (ERASCA INC), valued at $20.16M, representing 0.28% of its reported portfolio and ranking #41.
Has Evergreen Quality Fund GP, Ltd. been buying or selling ERAS?
In the latest 13F filing (Q3 2026), Evergreen Quality Fund GP, Ltd. held unchanged its position in ERAS.
Which other funds hold ERAS?
Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 63 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.